Skip to content

DSC Advisors, L.P.

Follow

13F filer, CIK 1299434, CHICAGO, IL

DSC Advisors, L.P. reported $77,894,363 across 30 holdings for the quarter ended 2023-09-30, in a 13F-HR filed 2023-11-14. Its ten largest share positions make up 93.44% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001085146-23-004455

Period
2023-09-30
Reported value
$77.9M
Holdings
30
Top 10 weight
93.44%
New
8
Sold out
6

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CVSadded+43,975$3.07M
ABTadded+28,275$2.74M
EHABadded+62,500$703K
ODPnew+10,000$462K
Vivid Seats Incadded+40,000$257K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ZVRAexited-49,100-$250K
NFLXexited-519-$229K
TEVAreduced-17,500-$178K
COMSexited-22,500-$38.5K
ADBEreduced-21-$10.7K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2023

Share positions as resolved from 13F-HR 0001085146-23-004455, largest first. % of portfolio is the value over $67,063,413, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 98,797 shares; 2023Q1: 130,280 shares; 2023Q2: 153,237 shares; 2023Q3: 197,212 shares 197,212$13.8M20.53%+43,975Timeline
R1 RCM INCR1 RCM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 1,000,000 shares; 2023Q1: 990,000 shares; 2023Q2: 841,000 shares; 2023Q3: 841,000 shares 841,000$12.7M18.9%0
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 82,500 shares; 2023Q1: 92,500 shares; 2023Q2: 100,000 shares; 2023Q3: 100,000 shares 100,000$8.85M13.19%0Timeline
ZBHZIMMER BIOMET HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 62,530 shares; 2023Q1: 62,529 shares; 2023Q2: 62,534 shares; 2023Q3: 64,742 shares 64,742$7.27M10.83%+2,208Timeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 41,415 shares; 2023Q3: 69,690 shares 69,690$6.75M10.06%+28,275Timeline
GOOGALPHABET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 46,000 shares; 2023Q1: 46,000 shares; 2023Q2: 46,000 shares; 2023Q3: 46,000 shares 46,000$6.07M9.04%0Timeline
EHTHEHEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 75,000 shares; 2023Q1: 192,500 shares; 2023Q2: 380,000 shares; 2023Q3: 410,000 shares 410,000$3.03M4.52%+30,000Timeline
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: 180,000 shares; 2023Q2: 310,000 shares; 2023Q3: 292,500 shares 292,500$2.98M4.45%-17,500Timeline
EHABENHABIT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 10,000 shares; 2023Q3: 72,500 shares 72,500$816K1.22%+62,500Timeline
ODPTHE ODP CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 10,000 shares 10,000$462K0.69%newTimeline
VYNEVYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: 115,000 shares; 2023Q2: 115,000 shares; 2023Q3: 115,000 shares 115,000$460K0.69%0Timeline
MSFTMICROSOFT CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 1,486 shares; 2023Q1: 1,250 shares; 2023Q2: 1,073 shares; 2023Q3: 1,179 shares 1,179$372K0.56%+106Timeline
GOOGLALPHABET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 3,753 shares; 2023Q1: 3,465 shares; 2023Q2: 2,865 shares; 2023Q3: 2,838 shares 2,838$371K0.55%-27Timeline
METAMETA PLATFORMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 2,262 shares; 2023Q1: 1,345 shares; 2023Q2: 1,192 shares; 2023Q3: 1,200 shares 1,200$360K0.54%+8Timeline
Vivid Seats IncVivid Seats IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 10,000 shares; 2023Q3: 50,000 shares 50,000$321K0.48%+40,000
VVISA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 1,354 shares; 2023Q1: 1,045 shares; 2023Q2: 1,290 shares; 2023Q3: 1,282 shares 1,282$295K0.44%-8Timeline
MAMASTERCARD INCORPORATEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 779 shares; 2023Q1: 622 shares; 2023Q2: 759 shares; 2023Q3: 741 shares 741$293K0.44%-18Timeline
ADBEADOBE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 534 shares; 2023Q3: 513 shares 513$262K0.39%-21Timeline
ACNACCENTURE PLC IRELANDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 784 shares; 2023Q1: not reported; 2023Q2: 813 shares; 2023Q3: 823 shares 823$253K0.38%+10Timeline
CRMSALESFORCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: 1,054 shares; 2023Q2: 1,184 shares; 2023Q3: 1,243 shares 1,243$252K0.38%+59Timeline
BRK-BBERKSHIRE HATHAWAY INC DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 674 shares; 2023Q1: not reported; 2023Q2: 628 shares; 2023Q3: 667 shares 667$234K0.35%+39Timeline
AAPLAPPLE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 1,778 shares; 2023Q1: 1,408 shares; 2023Q2: 1,190 shares; 2023Q3: 1,217 shares 1,217$208K0.31%+27Timeline
ORCLORACLE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 1,921 shares; 2023Q3: 1,944 shares 1,944$206K0.31%+23Timeline
ADTADT INC DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 30,000 shares 30,000$180K0.27%newTimeline
JETSETF SER SOLUTIONSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 10,000 shares 10,000$170K0.25%newTimeline
GENIGENIUS SPORTS LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 30,000 shares 30,000$160K0.24%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
GOOGALPHABET INC COMcall46,000$6.07Mnew
ABTABBOTT LABORATORIES COMcall36,000$3.49Mnew
UNITED STS NAT GAS FD LPUNITED STS NAT GAS FD LP UNIT PARcall100,000$683Knew
EHABENHABIT INC COMcall53,000$596Knew

Sold out in Q3 2023

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
BMRNBIOMARIN PHARMACEUTICAL INC25,000$2.17Mput
ZVRAZEVRA THERAPEUTICS INC131,700$672Kcall
ZVRAZEVRA THERAPEUTICS INC49,100$250Kshares
NFLXNETFLIX INC.519$229Kshares
HANESBRANDS INCHANESBRANDS INC50,000$227Kcall
COMSCOMSOVEREIGN HLDG CORP COM PAR22,500$38.5Kshares

How Q3 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001085146-23-004455 base2023-11-14acceptance time not in the bulk data set